作者: Axel C. Matzdorff , Gitta Kühnel , Bettina Kemkes-Matthes , Reinhard Voss
关键词:
摘要: Background: GP IIb/IIIa inhibitors have primarily been used short-term e.g., during PTCA. They failed to show clinical benefit long-term therapy. One reason might be the absence of a method monitor inhibitor activity. This study compared platelet aggregometry, rapid function analyzer (RPFA) test, single counting, and flow cytometric determination receptor occupancy measure IIb/IIIa-receptor